Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Free Cash Flow Growth (5y) (2022 - 2026)

Analysis

Catheter Precision (VTAK) Free Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.36%
Mar 31, 2026 19.10%
Dec 31, 2025 30.74%
Sep 30, 2025 18.38%
Jun 30, 2025 17.17%
Mar 31, 2025 19.79%
Dec 31, 2024 21.52%
Sep 30, 2024 18.88%
Jun 30, 2024 23.87%
Mar 31, 2024 26.46%
Dec 31, 2023 26.36%
Sep 30, 2023 15.76%
Jun 30, 2023 -5.80%
Mar 31, 2023 -36.57%
Dec 31, 2022 -11.35%